Anchor Capital Advisors LLC Decreases Stake in BWX Technologies, Inc. $BWXT

Anchor Capital Advisors LLC lessened its position in shares of BWX Technologies, Inc. (NYSE:BWXT) by 2.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 194,534 shares of the technology company’s stock after selling 5,117 shares during the quarter. Anchor Capital Advisors LLC owned 0.21% of BWX Technologies worth $33,623,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. M.D. Sass LLC purchased a new stake in BWX Technologies during the fourth quarter valued at $2,324,000. Bank of New York Mellon Corp increased its position in BWX Technologies by 3.7% in the fourth quarter. Bank of New York Mellon Corp now owns 1,184,944 shares of the technology company’s stock worth $204,806,000 after buying an additional 42,552 shares in the last quarter. Goldman Sachs Group Inc. increased its position in BWX Technologies by 55.5% in the fourth quarter. Goldman Sachs Group Inc. now owns 334,560 shares of the technology company’s stock worth $57,825,000 after buying an additional 119,435 shares in the last quarter. AXQ Capital LP bought a new position in shares of BWX Technologies in the fourth quarter worth about $397,000. Finally, Arcadia Investment Management Corp MI boosted its stake in shares of BWX Technologies by 426.6% in the fourth quarter. Arcadia Investment Management Corp MI now owns 7,109 shares of the technology company’s stock worth $1,229,000 after acquiring an additional 5,759 shares during the period. Hedge funds and other institutional investors own 94.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on BWXT. Wells Fargo & Company began coverage on BWX Technologies in a research note on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 price objective for the company. Truist Financial upped their price objective on BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. Zacks Research lowered BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. BTIG Research increased their price target on BWX Technologies from $225.00 to $235.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Finally, TD Securities started coverage on BWX Technologies in a research note on Thursday, March 12th. They set a “buy” rating and a $230.00 price target for the company. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, BWX Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.00.

Insider Activity at BWX Technologies

In other news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the sale, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at $41,472,181.71. This trade represents a 4.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the sale, the chief financial officer owned 6,884 shares in the company, valued at approximately $1,440,477. The trade was a 25.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

BWX Technologies Price Performance

NYSE:BWXT opened at $186.95 on Wednesday. The firm has a market capitalization of $17.13 billion, a price-to-earnings ratio of 49.99, a PEG ratio of 3.10 and a beta of 0.73. BWX Technologies, Inc. has a 1 year low of $126.91 and a 1 year high of $241.82. The business has a 50 day simple moving average of $212.55 and a 200-day simple moving average of $199.56. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33.

BWX Technologies (NYSE:BWXT) last posted its quarterly earnings data on Monday, May 4th. The technology company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.20. The business had revenue of $860.22 million during the quarter, compared to analyst estimates of $837.47 million. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The company’s revenue for the quarter was up 26.1% on a year-over-year basis. During the same period last year, the company earned $0.91 EPS. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. Equities analysts forecast that BWX Technologies, Inc. will post 4.71 EPS for the current year.

BWX Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, May 19th. BWX Technologies’s dividend payout ratio (DPR) is presently 28.88%.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.